Diabetes and cardiovascular risk evaluation and management in primary care:: progress and unresolved issues -: Rationale for a nationwide primary care project in Germany

被引：8

作者：

Böhler, S

Glaesmer, H

Pittrow, D

Lehnert, H

Stalla, GK

Zeiher, AM

März, W

Silber, S

Wehling, M

Ruf, G

Reinecke, A

机构：

[1] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-8027 Dresden, Germany

[2] Pfizer GmbH, Int Med Res, Freiburg, Germany

[3] Tech Univ Dresden, Inst Clin Pharmacol, Res Fed Publ Hlth Sachsen, D-8027 Dresden, Germany

[4] Otto Von Guericke Univ, Dept Endocrinol & Metab Disorders, Magdeburg, Germany

[5] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany

[6] Goethe Univ Frankfurt, Dept Cardiol Nephrol, D-6000 Frankfurt, Germany

[7] Univ Med Graz, Clin Inst Med & Chem, Diagnost Lab, Graz, Austria

[8] Heidelberg Univ, Inst Clin Pharmacol Mannheim, D-68167 Mannheim, Germany

[9] Pfizer GmbH, Clin Res, Karlsruhe, Germany

[10] Max Planck Inst Psychiat, Dept Clin Psychol & Epidemiol, D-80804 Munich, Germany

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2004年 / 112卷 / 04期

关键词：

coronary heart disease; type 2 diabetes mellitus; primary care; risk markers; epidemiology;

D O I：

10.1055/s-2004-817927

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review highlights established and more recently recognized risk factors for coronary heart disease (CHD) relevant for patients seen in primary care, emphasizing the key role of diabetes mellitus type 2. Recent trends in risk factor research as well as current methods of risk stratification, and new systemic markers are discussed. Beyond the need for more forceful public health strategies to improve early recognition and intervention, the necessity of an integrated comprehensive investigation of the overall characteristics of cardiovascular disease, especially in primary care patients as a prerequisite for future concerted actions is pointed out. Based on this, a large-scale epidemiological investigation focusing on CHD and diabetes in the primary care sector is suggested.

引用

收藏

页码：157 / 170

页数：14

相关论文

共 138 条

[21] Selection of thrombolytic therapy for individual patients: Development of a clinical model [J].

Califf, RM ;

Woodlief, LH ;

Harrell, FE ;

Lee, KL ;

White, HD ;

Guerci, A ;

Barbash, GI ;

Simes, RJ ;

Weaver, WDD ;

Simoons, ML ;

Topol, EJ .

AMERICAN HEART JOURNAL, 1997, 133 (06) :630-639

[22] C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].

CERMAK, J ;

KEY, NS ;

BACH, RR ;

BALLA, J ;

JACOB, HS ;

VERCELLOTTI, GM .

BLOOD, 1993, 82 (02) :513-520

[23] The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men [J].

Cho, E ;

Rimm, EB ;

Stampfer, MJ ;

Willett, WC ;

Hu, FB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :954-960

[24] A survey on the quality of care among patients with heart failure in Europe [J].

Cleland, JGF ;

Swedberg, K ;

Cohen-Solal, A ;

Cosin-Aguilar, J ;

Dietz, R ;

Follath, F ;

Gavazzi, A ;

Hobbs, R ;

Korewicki, J ;

Madeira, HC ;

Preda, I ;

van Gilst, WH ;

Widimsky, J ;

Mareev, V ;

Mason, J ;

Freemantle, N ;

Eastaugh, J .

EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (02) :123-132

[25] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].

Conroy, RM ;

Pyörälä, K ;

Fitzgerald, AP ;

Sans, S ;

Menotti, A ;

De Backer, G ;

De Bacquer, D ;

Ducimetière, P ;

Jousilahti, P ;

Keil, U ;

Njolstad, I ;

Oganov, RG ;

Thomsen, T ;

Tunstall-Pedoe, H ;

Tverdal, A ;

Wedel, H ;

Whincup, P ;

Wilhelmsen, L ;

Graham, IM .

EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003

[26] Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects:: Evidence for an anti-inflammatory effect? [J].

Dandona, P ;

Aljada, A ;

Mohanty, P ;

Ghanim, H ;

Hamouda, W ;

Assian, E ;

Ahmad, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3257-3265

[27] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].

Danesh, J ;

Whincup, P ;

Walker, M ;

Lennon, L ;

Thomson, A ;

Appleby, P ;

Gallimore, JR ;

Pepys, MB .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204

[28] The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study [J].

Dunstan, DW ;

Zimmet, PZ ;

Welborn, TA ;

de Courten, MP ;

Cameron, AJ ;

Sicree, RA ;

Dwyer, T ;

Colagiuri, S ;

Jolley, D ;

Knuiman, M ;

Atkins, R ;

Shaw, JE .

DIABETES CARE, 2002, 25 (05) :829-834

[29] Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease [J].

Ebrahim, S ;

Smith, GD .

BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7095) :1666-1674

[30] Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].

Eikelboom, JW ;

Lonn, E ;

Genest, J ;

Hankey, G ;

Yusuf, S .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375

← 1 2 3 4 5 6 7 8 9 10 →